DIGITAL SOLUTIONS FOR DRUG RECALL AND BANNED DRUG MANAGEMENT

Drug recalls are crucial for protecting public health when pharmaceutical products are found to be defective, contaminated, mislabeled, or unsafe. The traditional drug recall process involve fragmented information systems, manual communication, delayed identification of affected products, and difficulties in tracking products across the supply chain. These can increase the time required to identify, notify, and remove potentially harmful medicines from the market. This study an explores the role of digital solutions for improving drug recall management through different technologies such as blockchain, AI/ML system, serialization, electronic health record, traceability system, recall notification system. Digital platforms can support real-time communication among manufacturers, distributors, healthcare providers, regulatory authorities, pharmacies, and patients. Digital technologies can improve the speed, accuracy, transparency, and effectiveness of drug recalls, while reducing risk of human error. A framework for implementing digital drug recall solutions can strengthen pharmaceutical supply-chain safety and contribute to improve patient protection and public health outcomes.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-20
DOI
https://doi.org/10.5281/zenodo.24393710
Primary Topic
Pharmaceutical Quality and Counterfeiting
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

DIGITAL SOLUTIONS FOR DRUG RECALL AND BANNED DRUG MANAGEMENT

Abhijeet Welankiwar, Vinay Kamnani
2 links
Zenodo (CERN European Organization for Nuclear Research)
Pharmaceutical Quality and Counterfeiting
article

DIGITAL SOLUTIONS FOR DRUG RECALL AND BANNED DRUG MANAGEMENT

Abhijeet Welankiwar, Vinay Kamnani
article en

Abstract

Drug recalls are crucial for protecting public health when pharmaceutical products are found to be defective, contaminated, mislabeled, or unsafe. The traditional drug recall process involve fragmented information systems, manual communication, delayed identification of affected products, and difficulties in tracking products across the supply chain. These can increase the time required to identify, notify, and remove potentially harmful medicines from the market. This study an explores the role of digital solutions for improving drug recall management through different technologies such as blockchain, AI/ML system, serialization, electronic health record, traceability system, recall notification system. Digital platforms can support real-time communication among manufacturers, distributors, healthcare providers, regulatory authorities, pharmacies, and patients. Digital technologies can improve the speed, accuracy, transparency, and effectiveness of drug recalls, while reducing risk of human error. A framework for implementing digital drug recall solutions can strengthen pharmaceutical supply-chain safety and contribute to improve patient protection and public health outcomes.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Pharmaceutical Quality and Counterfeiting
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
DIGITAL SOLUTIONS FOR DRUG RECALL AND BANNED DRUG MANAGEMENT — Abhijeet Welankiwar, Vinay Kamnani · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS